By activating peroxisome proliferator-activated receptor gamma (PPAR-γ) and stabilizing HIF, 5-ASA helps restore the physiological hypoxia disrupted in inflammatory conditions, such as IBD (36, 43, 167, 168), highlighting the value of targeting oxygen tension to address intestinal inflammation and microbiota modulation. This evidence concerns the gene PPARG and inflammatory bowel disease.